Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02703571
Title Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals

colorectal cancer

pancreatic adenocarcinoma

Advanced Solid Tumor


Ribociclib + Trametinib

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.